Claritas Pharmaceuticals Stock Toronto S.E.
Equities
KLY
CA1806341071
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.79M |
---|---|---|---|---|---|
Net income 2019 | -21M -28.9M | Net income 2020 | 4M 5.51M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 969K | Net Debt 2020 | 920K 1.27M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
+0.27% | 42.86B | |
+11.10% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.05% | 25.15B | |
-24.63% | 18.63B | |
+26.53% | 12.37B | |
-3.24% | 11.92B | |
+6.74% | 11.21B |